Tomomi Makimura

1. Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan
   2021/09/16 by Kinue Nishioka, Tomomi Makimura, Akihiro Ishiguro +3 · 22 citations
   Pharmacology, Toxicology and Pharmaceutics · Economics, Econometrics and Finance · Mathematics · #Pharmacy and Medical Practices #Health Systems, Economic Evaluations, Quality of Life #Statistical Methods in Clinical Trials